Screening for gestational diabetes
Liufu V, Mundy L, Hiller JE
Record ID 32012000236
English
Authors' recommendations:
Maternal hyperglycaemia is less severe than that used to define overt diabetes, but is associated with adverse pregnancy outcomes and their effects may be ameliorated by treatment. Screening for gestational diabetes is not universal in Australia or New Zealand. Rates of Type 2 diabetes are increasing in Australasia. Given that women with gestational diabetes and their offspring are at greater risk of developing Type 2 diabetes, and there is an effective treatment for gestational diabetes, the screening and treatment for gestational hyperglycaemia may have beneficial impact from a public health perspective. The evidence for screening and subsequent treatment of gestational diabetes is well developed. Therefore HealthPACT has recommended that this information should be forwarded to the Royal Australian College of General Practitioners (RACGP), the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) and the National Screening Committee via Clinical Technical and Ethical Principal Committee (CTEPC).
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Mass Screening
- Pregnancy
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.